Overview
U.S. food and drug retailer's Q3 revenue slightly missed analyst expectations
Adjusted EPS for Q3 reported at $0.72
Company repurchased $750 mln of shares under accelerated share repurchase agreement
Outlook
Albertsons expects fiscal 2025 identical sales growth of 2.2% to 2.5%
Company forecasts fiscal 2025 adjusted EBITDA between $3.825 bln and $3.875 bln
Albertsons anticipates adjusted net income per share of $2.08 to $2.16 for fiscal 2025
Result Drivers
PHARMACY SALES - Strong growth in pharmacy sales was the primary driver of the 2.4% increase in identical sales
DIGITAL SALES - Digital sales increased by 21%, reflecting strategic investments in technology and AI
STORE CLOSURES AND FUEL SALES - Revenue growth was partially offset by store closures and lower fuel sales
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Slight Miss*
$19.12 bln
$19.17 bln (15 Analysts)
Q3 ADJUSTED EPS
$0.72
Q3 EPS
$0.55
Q3 ADJUSTED NET INCOME
$390.30 mln
Q3 ADJUSTED EBITDA
$1.04 bln
Q3 Dividend
$0.15
Q3 OPERATING INCOME
$489.70 mln
Q3 PRETAX PROFIT
$377.70 mln
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 7 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the food retail & distribution peer group is "buy"
Wall Street's median 12-month price target for Albertsons Companies Inc is $24.00, about 40.3% above its January 6 closing price of $17.11
The stock recently traded at 7 times the next 12-month earnings vs. a P/E of 8 three months ago
Press Release: ID:nBwMPhXa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)